DEF 14A

Company

ENDRA Life Sciences Inc.

Filed

May 24, 2023

Period of Report

July 6, 2023

Accession Number

0001654954-23-007157

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →